Kate Yandell is a Philadelphia-based freelance writer with a love for genomics and neuroscience. She writes for Spectrum‘s Toolbox section.
Kate Yandell
Contributing Writer
Spectrum
From this contributor
With new part, CRISPR can cut RNA in living cells
A new version of the gene-editing tool CRISPR can target and cut RNA, offering a way to tinker with the expression of autism genes.
With new part, CRISPR can cut RNA in living cells
By
Kate Yandell
15 July 2016 | 2 min read
Sequencing approach bares large variety of brain cell types
Analyzing gene expression in a vision center of the mouse brain has revealed 49 different classes of cells.
Sequencing approach bares large variety of brain cell types
By
Kate Yandell
24 February 2016 | 2 min read
Precise program traces firing patterns in neural networks
By tracking calcium’s movement, a new algorithm simultaneously delineates individual neurons’ shapes as well as their firing patterns.
Precise program traces firing patterns in neural networks
By
Kate Yandell
17 February 2016 | 2 min read
Simple steps let star-shaped brain cells thrive in culture
A new method allows researchers to culture cells known as astrocytes from human brains.
Simple steps let star-shaped brain cells thrive in culture
By
Kate Yandell
10 February 2016 | 3 min read
Method marks variants among repeated DNA segments
A new tool trawls sequencing data to reveal single-letter DNA swaps within large duplications.
Method marks variants among repeated DNA segments
By
Kate Yandell
9 December 2015 | 2 min read
Explore more from The Transmitter
Autism scientists push back on CDC’s inaccurate vaccine claims
The CDC website now falsely suggests that autism-vaccine research is still an open question, prompting distrust among researchers—some of whom anticipate “more unreliable statements coming from the junta that took over” the agency.
Autism scientists push back on CDC’s inaccurate vaccine claims
The CDC website now falsely suggests that autism-vaccine research is still an open question, prompting distrust among researchers—some of whom anticipate “more unreliable statements coming from the junta that took over” the agency.
By
The Transmitter
21 November 2025 | 6 min read
Gene replacement therapy normalizes some traits in SYNGAP1 model mice
The first published virus-based gene therapy for SYNGAP1 deletion yields benefits despite the gene’s long length and complexity.
Gene replacement therapy normalizes some traits in SYNGAP1 model mice
The first published virus-based gene therapy for SYNGAP1 deletion yields benefits despite the gene’s long length and complexity.
By
Charles Q. Choi
20 November 2025 | 5 min read
Does AI understand what it produces? Henk de Regt explores how we might assess understanding in machines and humans
Building on his philosophy of how scientists understand what they work on, de Regt is extending his approach to test understanding in machines.
Does AI understand what it produces? Henk de Regt explores how we might assess understanding in machines and humans
Building on his philosophy of how scientists understand what they work on, de Regt is extending his approach to test understanding in machines.
By
Paul Middlebrooks
19 November 2025 | 1 min read